Search

everythinglearnresearchcommunity

for

Search:↓

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Topical DHEA safely increases skin oil production.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Locally made finasteride tablets work the same as imported ones.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Sex steroid hormones are essential for reproductive health and overall well-being.

Hirsutism treatment should focus more on patient needs and quality of life.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.